Beta-blocker therapy for heart attack patients
Part of Heart & circulation clinical trials.
This trial tests a heart medication (a cardio-selective beta-blocker) given during a heart attack to see if it reduces damage to the heart muscle. It might help people having their first heart attack who are treated quickly with angioplasty (a procedure to open blocked arteries).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old
- You are having your first heart attack (ST-elevation type) and will get angioplasty within 12 hours of symptoms starting
- You are not already taking a beta-blocker medicine
- Your blood pressure and heart rate are stable (not too low)
- You do not have severe heart failure or other serious heart rhythm problems
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new device that may help support the heart during emergency treatment for a severe heart attack. It is for patients who have had symptoms for 6 to 24 hours and have a weakened heart muscle.
This trial tests whether a low-dose clot-busting medicine placed into the heart artery after a primary stent can improve outcomes in people with a certain type of heart attack. It also involves short hospital follow-ups and a heart MRI to look at how the heart is recovering.
This trial tests whether giving a medication before angioplasty reduces damage to the heart muscle in people having a severe heart attack. It may help improve blood flow and recovery.
This study tests whether a remote, arm-based treatment done around the time of a heart attack can improve outcomes in people with STEMI (a serious heart-attack type). Some participants receive the real treatment and some receive a sham version, while others may be followed observationally depending on how long ago symptoms started.
This trial is testing whether giving a beta-blocker medication (metoprolol) early after a heart attack can help people who have a fast heart rate or low blood pressure but no signs of organ failure. The goal is to see if this treatment improves recovery.
This trial tests a new way to treat heart attacks by using a special balloon to deliver medication to the heart's small blood vessels during a standard stenting procedure. It may help reduce damage to the heart muscle after a heart attack.
Hear when a new STEMI trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.